Gilead Sciences has announced the signing of voluntary licencing agreements with six generic pharmaceutical manufacturers to ...

Gilead Sciences is granting licenses to six companies to produce lenacapavir for pre-exposure prophylaxis, as well as for ...

Gilead signs non-exclusive, royalty-free voluntary licensing agreements with six generic companies to market its ...

The collaboration supports efforts for HIV prevention through PrEP, emphasizing Hetero’s commitment to improving HIV care.

If approved, the six manufacturers – Dr Reddy’s Laboratories Limited, Emcure, Eva Pharma, Ferozsons Laboratories Limited, ...

It is one of six global partners to have signed a voluntary licence agreement with Gilead to produce a high-quality generic ...

Six drugmakers sign agreements with Gilead Sciences to produce generic lenacapavir, a long-acting HIV drug, amid patent ...

Gilead Sciences, Inc. has announced that it has signed non-exclusive, royalty-free voluntary licensing agreements with six ...

HIV expert Linda-Gail Bekker talks to The Conversation Weekly about promising results from a trial of a new drug for HIV ...

Ferozsons Laboratories Limited (Ferozsons), a Pakistani pharmaceutical, has entered into a non-exclusive voluntary license ...

A new licensing agreement from Gilead Sciences and six generic drug manufacturers is poised to transform HIV prevention ...